Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Cardiovascular Diseases × Allopurinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperuricemia 3 Tumor Lysis Syndrome 2 Lymphoma 2 Leukemia 2 Sarcoma, Alveolar Soft Part 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Inflammation 1 Gout 1 Chondrosarcoma 1 Cardiovascular Diseases 1 Arthritis 1

Interventions

Aspirin 2 ficlatuzumab 1 Vorinostat 1 Raloxifene Hydrochloride 1 Omeprazole 1 Naproxen 1 Febuxostat 1 Erlotinib Hydrochloride 1 Colchicine 1 Bortezomib 1 Allopurinol 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡